Menopause is the condition when a woman no longer manifests menstrual periods. GSM (Genitourinary Syndrome) is the acronym to describe possible symptoms of this condition. Vaginal dryness can be a particular problem for women entering menopause, it can make the intercourse painful and may cause the increase in the need to urinate. Aim of this study is to evaluate the efficacy of combined fractional CO2 (10.500 nm) ablative and 1540 nm non-ablative lasers on these symptoms.
40 postmenopausal non-estrogenized women with moderate to severe vaginal atrophy referring symptoms related to GSM were recruited. A treatment cycle included 3 laser applications (every 4 weeks), was performed. Time points of the study were baseline (T1), week 4 (T2), week 8 (T3) and week 12 (T4).. Results evaluation was done with a modified FSFI (Female Sexual Function Index) and a modified Stress Urinary Incontinence scale.
A significant improvement both of FSFI total score and each individual FSFI domain score was observed. No undesired side effects or short-term or long-term complications were shown.
This study shows that the “two wavelengths endovaginal laser treatment” is a safe and effective technique to treat signs and symptoms related to GSM syndrome. For the treatment of women with severe urogenital symptoms who do not benefit from lifestyle changes, vaginal moisturizers or local estrogen therapy, clinicians should consider the use of vaginal fractional laser treatment. This article is protected by copyright. All rights reserved.
This article is protected by copyright. All rights reserved.